What is the share price of Sharma East India Hospitals and Medical Research Ltd (SHARMEH) today?
The share price of SHARMEH as on 12th October 2026 is ₹80.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Sharma East India Hospitals and Medical Research Ltd (SHARMEH) share?
The past returns of Sharma East India Hospitals and Medical Research Ltd (SHARMEH) share are- Past 1 week: -10.67%
- Past 1 month: -18.79%
- Past 3 months: -23.77%
- Past 6 months: -19.68%
- Past 1 year: -46.26%
- Past 3 years: N/A%
- Past 5 years: 240.39%
What are the peers or stocks similar to Sharma East India Hospitals and Medical Research Ltd (SHARMEH)?
The peers or stocks similar to Sharma East India Hospitals and Medical Research Ltd (SHARMEH) include:What is the market cap of Sharma East India Hospitals and Medical Research Ltd (SHARMEH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sharma East India Hospitals and Medical Research Ltd (SHARMEH) is ₹26.96 Cr as of 12th October 2026.What is the 52 week high and low of Sharma East India Hospitals and Medical Research Ltd (SHARMEH) share?
The 52-week high of Sharma East India Hospitals and Medical Research Ltd (SHARMEH) is ₹172.90 and the 52-week low is ₹80.What is the PE and PB ratio of Sharma East India Hospitals and Medical Research Ltd (SHARMEH) stock?
The P/E (price-to-earnings) ratio of Sharma East India Hospitals and Medical Research Ltd (SHARMEH) is 21.57. The P/B (price-to-book) ratio is 1.97.Which sector does Sharma East India Hospitals and Medical Research Ltd (SHARMEH) belong to?
Sharma East India Hospitals and Medical Research Ltd (SHARMEH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Sharma East India Hospitals and Medical Research Ltd (SHARMEH) shares?
You can directly buy Sharma East India Hospitals and Medical Research Ltd (SHARMEH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Sharma East India Hospitals and Medical Research Ltd
SHARMEH Share Price
BSE₹80.402.07% (-1.70)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SHARMEH Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SHARMEH Performance & Key Metrics
SHARMEH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 22.85 | 1.97 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.80 | 5.62 | 0.51% |
SHARMEH Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SHARMEH Company Profile
Sharma East India Hospitals and Medical Research Ltd operates Jaipur Hospital, providing comprehensive healthcare services including surgeries, intensive care, and various specialty medical services.
APOLLOHOSP
PE Ratio
59.44
59.44
1Y Return
1.36%
1.36%
Buy Reco %
86.67
86.67
MANIPALHOS
PE Ratio
103.38
103.38
1Y Return
1.81%
1.81%
Buy Reco %
66.67
66.67
MAXHEALTH
PE Ratio
59.64
59.64
1Y Return
24.26%
24.26%
Buy Reco %
83.33
83.33
PE Ratio
157.17
157.17
1Y Return
3.05%
3.05%
Buy Reco %
91.67
91.67
FORTIS
PE Ratio
56.98
56.98
1Y Return
30.85%
30.85%
Buy Reco %
90.00
90.00
SHARMEH Forecast
SHARMEH Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SHARMEH
SHARMEH
Income
Balance Sheet
Cash Flow
Quarterly Normal View
SHARMEH Income Statement
SHARMEH Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7.11 | 6.72 | 9.05 | 8.19 | 6.22 | 9.51 | 9.43 | 9.65 | 7.49 | 10.80 | ||||||||||
Operating & Other expenses | 6.13 | 5.86 | 7.90 | 7.29 | 5.17 | 8.55 | 8.45 | 8.84 | 6.46 | 9.91 | ||||||||||
EBITDA | 0.98 | 0.86 | 1.15 | 0.90 | 1.05 | 0.96 | 0.98 | 0.81 | 1.03 | 0.89 | ||||||||||
| Depreciation/Amortization | 0.46 | 0.35 | 0.44 | 0.36 | 0.67 | 0.42 | 0.43 | 0.43 | 0.44 | 0.36 | ||||||||||
| PBIT | 0.52 | 0.51 | 0.71 | 0.54 | 0.38 | 0.54 | 0.55 | 0.38 | 0.59 | 0.53 | ||||||||||
| Interest & Other Items | 0.14 | 0.17 | 0.25 | 0.15 | 0.14 | 0.11 | 0.10 | 0.13 | 0.16 | 0.19 | ||||||||||
| PBT | 0.38 | 0.34 | 0.46 | 0.39 | 0.24 | 0.43 | 0.45 | 0.25 | 0.43 | 0.34 | ||||||||||
| Taxes & Other Items | 0.34 | 0.09 | 0.12 | 0.10 | -0.14 | 0.11 | 0.13 | 0.07 | 0.00 | 0.09 | ||||||||||
| Net Income | 0.04 | 0.25 | 0.34 | 0.29 | 0.38 | 0.32 | 0.32 | 0.18 | 0.43 | 0.25 | ||||||||||
| EPS | 0.12 | 0.77 | 1.03 | 0.88 | 1.12 | 0.97 | 0.97 | 0.54 | 1.31 | 0.79 |
SHARMEH Company Updates
SHARMEH Stock Peers
SHARMEH Past Performance & Peer Comparison
SHARMEH Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Sharma East India Hospitals and Medical Research Ltd | 21.57 | 1.97 | — |
| Apollo Hospitals Enterprise Limited | 59.44 | 11.57 | 0.25% |
| Manipal Health Enterprises Limited | 103.38 | 10.48 | — |
| Max Healthcare Institute Limited | 59.64 | 8.00 | 0.23% |
Compare valuation on ScreenerSHARMEH Stock Price Comparison
Compare SHARMEH with any stock or ETFCompare SHARMEH with any stock or ETF
SHARMEH
SHARMEH Holdings
SHARMEH Shareholdings
SHARMEH Promoter Holdings Trend
SHARMEH Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
SHARMEH Institutional Holdings Trend
SHARMEH Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SHARMEH Shareholding Pattern
SHARMEH Shareholding Pattern
SHARMEH Shareholding History
SHARMEH Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing SHARMEH stock
smallcases containing SHARMEH stock
Looks like this stock is not in any smallcase yet.
SHARMEH Events
SHARMEH Events
SHARMEH Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SHARMEH has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SHARMEH Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SHARMEH has not given any dividends in last 5 years
SHARMEH Dividends
SHARMEH Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSHARMEH Stock News & Opinions
SHARMEH Stock News & Opinions
Articles & Videos
Earnings
Earnings
Sharma East India Hosp and Medical Research standalone net profit rises 16.22% in the March 2026 quarterNet profit of Sharma East India Hosp and Medical Research rose 16.22% to Rs 0.43 crore in the quarter ended March 2026 as against Rs 0.37 crore during the previous quarter ended March 2025. Sales rose 24.92% to Rs 7.47 crore in the quarter ended March 2026 as against Rs 5.98 crore during the previous quarter ended March 2025. For the full year,net profit remain constant at Rs 1.24 crore in the year ended March 2026 and also during the previous year ended March 2025. Sales rose 20.29% to Rs 35.93 crore in the year ended March 2026 as against Rs 29.87 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales7.475.98 25 35.9329.87 20 OPM %13.5213.55 -10.1012.25 - PBDT0.870.90 -3 3.283.25 1 PBT0.430.23 87 1.561.41 11 NP0.430.37 16 1.241.24 0 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Sharma East India Hosp & Medical Res. to discuss resultsSharma East India Hosp & Medical Res. will hold a meeting of the Board of Directors of the Company on 30 May 2026.
4 months agoCapital Market - Live
Earnings
Earnings
Sharma East India Hosp and Medical Research standalone net profit declines 37.93% in the December 2025 quarterNet profit of Sharma East India Hosp and Medical Research declined 37.93% to Rs 0.18 crore in the quarter ended December 2025 as against Rs 0.29 crore during the previous quarter ended December 2024. Sales rose 17.91% to Rs 9.61 crore in the quarter ended December 2025 as against Rs 8.15 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales9.618.15 18 OPM %7.9110.55 - PBDT0.680.75 -9 PBT0.250.39 -36 NP0.180.29 -38 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Sharma East India Hosp & Medical Res. to conduct board meetingSharma East India Hosp & Medical Res. will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Earnings
Sharma East India Hosp and Medical Research standalone net profit declines 5.88% in the September 2025 quarterNet profit of Sharma East India Hosp and Medical Research declined 5.88% to Rs 0.32 crore in the quarter ended September 2025 as against Rs 0.34 crore during the previous quarter ended September 2024. Sales rose 3.99% to Rs 9.38 crore in the quarter ended September 2025 as against Rs 9.02 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales9.389.02 4 OPM %9.9112.31 - PBDT0.880.90 -2 PBT0.450.46 -2 NP0.320.34 -6 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Sharma East India Hosp & Medical Res. to convene board meetingSharma East India Hosp & Medical Res. will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Corporate
Sharma East India Hosp & Medical Res. to conduct AGMSharma East India Hosp & Medical Res. announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Earnings
Earnings
Sharma East India Hosp and Medical Research standalone net profit rises 28.00% in the June 2025 quarterNet profit of Sharma East India Hosp and Medical Research rose 28.00% to Rs 0.32 crore in the quarter ended June 2025 as against Rs 0.25 crore during the previous quarter ended June 2024. Sales rose 40.92% to Rs 9.47 crore in the quarter ended June 2025 as against Rs 6.72 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales9.476.72 41 OPM %9.7112.80 - PBDT0.850.69 23 PBT0.430.34 26 NP0.320.25 28 Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Corporate
Sharma East India Hosp & Medical Res. to announce Quarterly ResultSharma East India Hosp & Medical Res. will hold a meeting of the Board of Directors of the Company on 8 August 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Earnings
Earnings
Sharma East India Hosp and Medical Research standalone net profit rises 825.00% in the March 2025 quarterNet profit of Sharma East India Hosp and Medical Research rose 825.00% to Rs 0.37 crore in the quarter ended March 2025 as against Rs 0.04 crore during the previous quarter ended March 2024. Sales rose 232.22% to Rs 5.98 crore in the quarter ended March 2025 as against Rs 1.80 crore during the previous quarter ended March 2024. For the full year,net profit rose 87.88% to Rs 1.24 crore in the year ended March 2025 as against Rs 0.66 crore during the previous year ended March 2024. Sales rose 61.29% to Rs 29.87 crore in the year ended March 2025 as against Rs 18.52 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales5.981.80 232 29.8718.52 61 OPM %13.55-240.56 -12.25-10.15 - PBDT0.900.84 7 3.252.48 31 PBT0.230.38 -39 1.411.00 41 NP0.370.04 825 1.240.66 88 Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 26.92%, vs industry avg of 18.03%
Over the last 5 years, market share increased from 0.02% to 0.03%
Over the last 5 years, net income has grown at a yearly rate of 15.05%, vs industry avg of 62.59%